-
1
-
-
20144370344
-
C. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally
-
Dye C, Watt C J, Bleed D M, et al. C. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally[J]. JAMA, 2005, 293(22): 2790-2793.
-
(2005)
JAMA
, vol.293
, Issue.22
, pp. 2790-2793
-
-
Dye, C.1
Watt, C.J.2
Bleed, D.M.3
-
2
-
-
84865096989
-
-
Chinese source
-
Chinese source, 2000 , 23 (10) :621.
-
(2000)
, vol.23
, Issue.10
, pp. 621
-
-
-
3
-
-
33644902345
-
Adverse reactions to first-line antituberculosis drugs
-
Forget E J, Menzies D. Adverse reactions to first-line antituberculosis drugs[J]. Expert Opin Drug Saf, 2006, 5(2): 231-249.
-
(2006)
J Expert Opin Drug Saf
, vol.5
, Issue.2
, pp. 231-249
-
-
Forget, E.J.1
Menzies, D.2
-
4
-
-
42449142373
-
Pharmacogenomics of anti-TB drugs-related hepatotoxicity
-
Roy P D, Majumder M, Roy B. Pharmacogenomics of anti-TB drugs-related hepatotoxicity[J]. Pharmacogenomics, 2008, 9(3): 311-321.
-
(2008)
J Pharmacogenomics
, vol.9
, Issue.3
, pp. 311-321
-
-
Roy, P.D.1
Majumder, M.2
Roy, B.3
-
5
-
-
33750066952
-
Antituberculosis drugs and hepatotoxicity
-
Yew W W, Leung C C. Antituberculosis drugs and hepatotoxicity[J]. Respirology, 2006, 11(6): 699-707.
-
(2006)
J Respirology
, vol.11
, Issue.6
, pp. 699-707
-
-
Yew, W.W.1
Leung C, C.2
-
6
-
-
33644808882
-
Monitoring and management of antituberculosis drug induced hepatotoxicity
-
Agal S, Baijal R, Pramanik S, et al. Monitoring and management of antituberculosis drug induced hepatotoxicity[J]. J Gastroenterol Hepatol, 2005, 20(11): 1745-1752.
-
(2005)
J Gastroenterol Hepatol
, vol.20
, Issue.11
, pp. 1745-1752
-
-
Agal, S.1
Baijal, R.2
Pramanik, S.3
-
7
-
-
39149145797
-
Antituberculosis drug-induced hepatotoxicity: Concise upto-date review
-
Tostmann A, Boeree M J, Aarnoutse R E, et al. Antituberculosis drug-induced hepatotoxicity: Concise upto-date review[J]. J Gastroenterol Hepatol, 2008, 23(2): 192-202.
-
(2008)
J Gastroenterol Hepatol
, vol.23
, Issue.2
, pp. 192-202
-
-
Tostmann, A.1
Boeree, M.J.2
Aarnoutse, R.E.3
-
8
-
-
33749856322
-
An official ATS statement: Hepatotoxicity of antituberculosis therapy
-
Saukkonen J J, Cohn D L, Jasmer R M, et al. An official ATS statement: Hepatotoxicity of antituberculosis therapy[J]. Am J Respir Crit Care Med, 2006, 174(8):935-952.
-
(2006)
Am J Respir Crit Care Med
, vol.174
, Issue.8
, pp. 935-952
-
-
Saukkonen, J.J.1
Cohn, D.L.2
Jasmer, R.M.3
-
9
-
-
84865087965
-
-
Chinese source
-
Chinese source, 2002,18(6):330-333.
-
(2002)
, vol.18
, Issue.6
, pp. 330-333
-
-
-
10
-
-
75149127243
-
GSTT1 and GSTM1 null mutations and adverse reactions induced by antituberculosis drugs in Koreans
-
Kim S H, Kim S H, Yoon H J, et al. GSTT1 and GSTM1 null mutations and adverse reactions induced by antituberculosis drugs in Koreans[J]. Tuberculosis, 2010, 90 (1): 39-43.
-
(2010)
J Tuberculosis
, vol.90
, Issue.1
, pp. 39-43
-
-
Kim, S.H.1
Kim, S.H.2
Yoon, H.J.3
-
11
-
-
78851470285
-
Role of polymorphic N-acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis
-
Bose P D, Sarma M P, Medhi S, et al. Role of polymorphic N-acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis[J]. J Gastroenterol Hepatol, 2011, 26(2): 312-318.
-
(2011)
J Gastroenterol Hepatol
, vol.26
, Issue.2
, pp. 312-318
-
-
Bose, P.D.1
Sarma, M.P.2
Medhi, S.3
-
12
-
-
0035436665
-
Reactive metabolites and their role in drug reactions
-
Naisbitt D J, Williams D P, Pirmohamed M, et al. Reactive metabolites and their role in drug reactions[J]. Curr Opin Allergy Clin Immunol, 2001, 1(4):317-325.
-
(2001)
Curr Opin Allergy Clin Immunol
, vol.1
, Issue.4
, pp. 317-325
-
-
Naisbitt, D.J.1
Williams, D.P.2
Pirmohamed, M.3
-
13
-
-
0034653362
-
Glutathione S-transferase: Genetics and role in toxicology
-
Strange R C, Jones P W, Fryer A A. Glutathione S-transferase: Genetics and role in toxicology[J]. Toxicol Lett, 2000, 112-113:357-363.
-
(2000)
J Toxicol Lett
, vol.112-113
, pp. 357-363
-
-
Strange, R.C.1
Jones, P.W.2
Fryer, A.A.3
-
14
-
-
0034797313
-
Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation
-
Roy B, Chowdhury A, Kundu S, et al. Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation[J]. J Gastroenterol Hepatol, 2001, 16(9): 1033-1037.
-
(2001)
J Gastroenterol Hepatol
, vol.16
, Issue.9
, pp. 1033-1037
-
-
Roy, B.1
Chowdhury, A.2
Kundu, S.3
-
15
-
-
34249284163
-
Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H: quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury
-
Huang Y S, Su W J, Huang Y H, et al. Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H: quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury[J]. J Hepatol, 2007, 47(1): 128-134.
-
(2007)
J Hepatol
, vol.47
, Issue.1
, pp. 128-134
-
-
Huang, Y.S.1
Su, W.J.2
Huang, Y.H.3
-
16
-
-
44949221609
-
Infuence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population
-
Leiro V, Ferǹandez-Villar A, Valverde D, et al. Infuence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population[J]. Liver Int, 2008, 28(6): 835-839.
-
(2008)
J Liver Int
, vol.28
, Issue.6
, pp. 835-839
-
-
Leiro, V.1
Ferǹandez-Villar, A.2
Valverde, D.3
-
17
-
-
0027367823
-
Identficiation of class mugultathoine S-transferase genes GSTM1-GSTM5 on human chromosome lp13
-
Peatson W R,Verachek W R, Xu S J, et al. Identficiation of class mugultathoine S-transferase genes GSTM1-GSTM5 on human chromosome lp13[J]. Am J Hum Ganet, 1993, 53(1): 220-233.
-
(1993)
Am J Hum Ganet
, vol.53
, Issue.1
, pp. 220-233
-
-
Peatson, W.R.1
Verachek, W.R.2
Xu, S.J.3
-
18
-
-
77954482791
-
GSTT1 and GSTM1 gene deletions are not associated with hepatotoxicity caused by antitubercular drugs
-
Chatterjee S, Lyle N, Mandal A, et al. GSTT1 and GSTM1 gene deletions are not associated with hepatotoxicity caused by antitubercular drugs[J]. J Clin Pharm Ther, 2010, 35(4): 465-470.
-
(2010)
J Clin Pharm Ther
, vol.35
, Issue.4
, pp. 465-470
-
-
Chatterjee, S.1
Lyle, N.2
Mandal, A.3
|